The Pharma Data

JANUARY 6, 2021

“Further, PDE4-inhibition is a well-documented pharmacological target for a number of other inflammatory indications, and we look forward to advancing our clinical research to realize the full potential of orismilast for the benefit of the millions of patients living with inflammatory conditions globally,” adds Professor Sommer.

FDA Approval 52

FDA Approval FDA Clinical Development Clinical Research 52

The Pharma Data

OCTOBER 22, 2020

The Company intends to use the net proceeds from this offering to support its planned New Drug Application submission for oral sulopenem for the treatment of uncomplicated urinary tract infections in patients with quinolone-resistant pathogens, the continued clinical development of sulopenem, and for working capital and general corporate purposes.

Pharmaceutical Companies 40

Pharmaceutical Companies Clinical Trials Clinical Development Pharmaceuticals 40

The Pharma Data

JANUARY 24, 2021

Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Toronto, Ontario–(Newsfile Corp. – January 25, 2021) – PharmaDrug Inc.

FDA 52

FDA Drugs Clinical Development Pharmaceutical Companies 52

The Pharma Data

OCTOBER 19, 2020

van de Laar has over 20 years of experience in biotechnology scale up and manufacturing and will be responsible for leading the Company’s preparations for commercial readiness, CMC activities and global supply chain management. Dr. Kraan joins AM-Pharma from Pierre Fabre S.A.,

Trials 40

Trials Small Molecule Cell Biology Pharmaceutical Companies 40

Drug Discovery World

OCTOBER 16, 2023

The country’s pioneering genomics research, crucial for future drug discovery, is demonstrated by institutes like the Wellcome Sanger Institute and projects like the 100,000 Genomes Project. Cambridge is a focal point for many pharmaceutical companies working in this therapeutic area.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Agency IQ

FEBRUARY 12, 2024

The consortium is funded by a public-private partnership called the Accelerating Medicines Partnership (AMP) , through which the Foundation for the NIH (FNIH) administers funds provided by industry, government, and nonprofits to scientists working on applicable basic or clinical research to advance gene therapy development for rare diseases.

FDA 40

FDA Therapies Clinical Trials Virus 40

The Pharma Data

JANUARY 14, 2021

Associate Professor of Medicine at UCLA, Co-director of the Gastrointestinal Oncology Program and Director of Early Phase Clinical Research at the Jonsson Comprehensive Cancer Center. This vision is what defines us and guides our research, clinical development and partnerships. Wainberg, M.D., Wainberg, M.D.,

Trials 52

Trials Treatment Therapies Clinical Trials 52

Drug Discovery World

JANUARY 12, 2023

Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design. DDW shared a global data analysis from Phesi, which showed the extent of the impact from the war in Ukraine on clinical development.

Clinical Trials 243

Clinical Trials Drugs Trials Pharmaceutical Companies 243

Drug Discovery World

AUGUST 8, 2022

DDW Editor Reece Armstrong speaks to Stephanie Seremetis, Chief Medical Officer, Rare Blood Disorders at Novo Nordisk to get her response to the company’s latest study results for its Mim8 antibody. We look forward to moving into phase 3 clinical development, which is due to commence in Q4 2022.

Treatment 130

Treatment Clinical Trials International Disease 130

Advarra

AUGUST 10, 2023

The Orphan Drug Act creates incentives for developing orphan drugs to treat such diseases. The FDA plans to launch Operation Warp Speed for Rare Diseases in 2023 with a focus on increased communication between the agency and drug and biotech companies. Research sites without access to an IBC may consider relying on a commercial IBC.

Drug Development 52

Drug Development Disease Engineering Therapies 52

Molecule Blog

MARCH 17, 2023

The university then licenses the IP to an existing pharmaceutical company or a biotech startup, which takes on Investigational New Drug (IND) enabling studies. This phase is typically executed by private biotech labs and/or contract research organizations, funded by venture capital and/or pharma balance sheets.

Engineering 52

Engineering Research Government Clinical Trials 52

The Pharma Data

NOVEMBER 19, 2020

Baffa joins the company from Medisix, where he held the role of Head of R&D and CMO. Previously, Baffa was Therapeutic Area Head of Oncology, Global Clinical Development for Shire. where he led the company’s operations during a period of rapid growth. Cogentus Pharmaceuticals, Inc., Affymetrix, Inc.,

Laboratories 52

Laboratories Research Laboratories Organic Chemistry Science 52

The Pharma Data

OCTOBER 27, 2020

Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420, expected to begin in November 2020, and perform all remaining preclinical work for MP0423 and Novartis will conduct Phase 2 and Phase 3 clinical trials, with Molecular Partners as sponsor of these trials.

Therapies 52

Therapies Virus Treatment Clinical Trials 52

The Pharma Data

JUNE 26, 2021

RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. About EXPLORER The EXPLORER clinical research program is unmatched by any oral anticoagulant in the Factor Xa inhibitor class in its size, scope and ambition.

Doctors 52

Doctors Hospitals Clinical Trials Treatment 52

The Pharma Data

OCTOBER 14, 2020

AOP Orphan – AOP Orphan Pharmaceuticals took over the Viennese pharmaceutical company Amomed and the Luxembourgish health-tech company SciPharm. AOP anticipates new opportunities in Austria as a hub for research and business. All jobs have been maintained and the workforce has grown from about 220 to 350.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals DNA 52